Associated Papers
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders.
Djidjik R et al.
Frontiers in Immunology, 2025
Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers.
Kasembeli MM et al.
Blood, 2023
Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome.
Tar I et al.
Central-european Journal of Immunology, 2023
Malignancy in STAT3 Deficient Hyper IgE Syndrome.
Urban A et al.
Journal of Clinical Immunology, 2022
Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
Asano T et al.
The Journal of Experimental Medicine, 2021
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED et al.
Cancers, 2019
Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome.
Farmand S et al.
European Journal of Immunology, 2018
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.
Bocchini CE et al.
Blood, 2016
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.
Zhu S et al.
Blood, 2014
Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome.
Freeman AF et al.
Journal of Clinical Immunology, 2013
A STAT3 mutation in hyper-immunoglobulin E syndrome: A case report.
Haenen F et al.
Journal of Pediatric Genetics, 2013
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.
Chandesris MO et al.
Medicine, 2012
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C et al.
The Journal of Allergy and Clinical Immunology, 2010
STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families.
Wjst M et al.
European Journal of Human Genetics : Ejhg, 2009
Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML et al.
Current Opinion in Allergy and Clinical Immunology, 2008
STAT3 mutations in the hyper-IgE syndrome.
Holland SM et al.
The New England Journal of Medicine, 2007